CDC20 and MELK as Bioinformatics-Derived Hub Genes in Breast Cancer: Expression Patterns Across Histological Grades

Abstract

Background: Breast cancer is a molecularly heterogeneous disease in which histological grade reflects differences in differentiation and biological behavior. Identifying molecular alterations associated with tumor grade may improve our understanding of breast cancer progression and provide candidate biomarkers for further investigation. Objectives: This study aimed to identify candidate hub genes using integrative bioinformatics analysis and to experimentally evaluate the expression of selected genes and literature-supported microRNAs in Grade II and Grade III breast cancer tissues. Methods: The publicly available breast cancer transcriptomic dataset GSE10810 was analyzed separately for Grade I, Grade II, and Grade III tumors compared with non-tumor breast tissues. Differentially expressed genes were analyzed using pathway enrichment and protein–protein interaction network analysis; MCODE module detection and CytoHubba degree-based hub-gene ranking were then performed. Shared hub genes were further evaluated using the GOBO database. Experimentally supported miRNA–target interactions were retrieved using multiMiR with miRTarBase and TarBase and then prioritized based on the literature. Expression of CDC20, MELK, miR-192-5p, and miR-17-5p was assessed by qRT-PCR in 30 breast cancer tissues (15 Grade II and 15 Grade III) and 30 matched adjacent normal tissues. Results: The bioinformatics workflow identified CDC20 and MELK as the only hub genes shared by the Grade II and Grade III networks. GOBO analysis supported their increased expression in breast cancer. In the clinical cohort, CDC20 and MELK were significantly dysregulated in tumor tissues relative to matched adjacent normal tissues, whereas miR-192 and miR-17 showed changes in the opposite direction. However, clinicopathological analysis showed no statistically significant differences between Grade II and Grade III tumors for any of the four biomarkers (CDC20, P = 0.820; MELK, P = 0.820; miR-192, P = 0.787; miR-17, P = 0.443). Spearman analysis also showed no statistically significant correlations among the four biomarkers; CDC20–MELK and miR-192–miR-17 showed positive but non-significant correlations (ρ = 0.324, P = 0.081 and ρ = 0.358, P = 0.052, respectively). No statistically significant associations were detected with the other available clinicopathological variables. Conclusions: CDC20, MELK, and the candidate miRNAs miR-192 and miR-17 showed tumor-associated expression changes in the studied breast cancer cohort. The present data do not support a statistically significant association between these markers and histological grade or a significant co-expression relationship among the four biomarkers. Larger cohorts and functional studies are required to determine whether these molecules have grade-related or mechanistic relevance in breast cancer.

Description

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By